Mudanjiang, China

Yafang Guo

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Jiuzhitang Co., Ltd., Mudanjiang Youbo Pharmaceutical Co., Ltd.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yafang Guo: Innovator in Antithrombotic Research

Introduction

Yafang Guo is a notable inventor based in Mudanjiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit coagulation factors. His work is essential in the ongoing fight against thrombotic diseases.

Latest Patents

Yafang Guo holds a patent for an "Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof." This patent describes a purified oligosaccharide compound that exhibits antithrombotic activity. The invention includes a preparation method for the compound and its pharmaceutical applications as an intrinsic factor X-enzyme inhibitor, which is crucial for developing drugs aimed at preventing and treating thrombotic diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Yafang Guo has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Jiuzhitang Co., Ltd. and Mudanjiang Youbo Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in medicine.

Collaborations

Yafang Guo has collaborated with several professionals in his field, including Jikai Liu and Na Gao. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Yafang Guo's contributions to antithrombotic research through his innovative patent and collaborations with industry professionals highlight his importance in the pharmaceutical field. His work continues to pave the way for advancements in the treatment of thrombotic diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…